You are here

Vertex Pharmaceuticals

Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program

Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program

Fierce Biotech

Vertex Pharmaceuticals

Flag link:

Promising Vertex Pain Med Points to New Era for Analgesics

Promising Vertex Pain Med Points to New Era for Analgesics

BioSpace

Vertex Pharmaceuticals

post-surgical pain

Flag link:

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center

Fierce Biotech

Vertex Pharmaceuticals

Flag link:

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results

Clinical Trials Arena

Vertex Pharmaceuticals

beta thalassemia

Flag link:

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength

Yahoo/Reuters

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million

Reuters

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

Flag link:

Gene Editing Race Between Editas and Vertex, CRISPR Heats Up

Gene Editing Race Between Editas and Vertex, CRISPR Heats Up

BioSpace

Editas Medicine

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted

Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted

Fierce Biotech

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients

ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients

BioSpace

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Finding the big spenders beyond big pharma

Finding the big spenders beyond big pharma

EP Vantage

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Could This Move Make Vertex's Next Blockbuster Even Bigger?

Could This Move Make Vertex's Next Blockbuster Even Bigger?

Motley Fool

Vertex Pharmaceuticals

beta thalassemia

sickle cell disease

Flag link:

Gene Editing Therapeutics Could Hit the Market in 2023

Gene Editing Therapeutics Could Hit the Market in 2023

BioSpace

CRISPR Therapeutics

Vertex Pharmaceuticals

Intellia Therapeutics

Editas Medicine

Beam Therapeutics

Flag link:

Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Yahoo/Businesswire

Vertex Pharmaceuticals

CRISPR Therapeutics

sickle cell disease

beta thalassemia

Flag link:

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

Endpoints

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Vertex flexes its dealmaking muscle

Vertex flexes its dealmaking muscle

EP Vantage

Vertex Pharmaceuticals

Entrada Therapeutics

Tevard Biosciences

Duchenne Muscular Dystrophy

Flag link:

Pages